Return on Investment

Return on Investment: Concept Architecture

Orientation and learning roadmap

This page sets out the counterfactual, perspective, and monetary flows needed for an interpretable return figure. It then works through a discounted example and explains when the result helps with health and public-sector decisions.

Define the investment and comparison

Specify the intervention, the alternative that would otherwise occur, the population, the decision-maker's perspective, and the analysis horizon. Benefits and costs attributed to the investment should be incremental to that alternative, rather than gross activity or savings that would have occurred anyway.

Count programme setup, delivery, maintenance, and any displaced or induced costs consistently with the stated perspective. Record who receives each benefit and who pays each cost, since an employer's cash return, a health system's budget impact, and society's wider economic return can differ substantially. Avoid counting the same avoided cost as both a saving and a separately monetised benefit.

Formula and reporting convention

One common convention expresses the net monetary gain per unit of incremental investment. Because publications also use “return on investment” for a gross benefit-to-cost ratio, every result should display the exact numerator and denominator rather than relying on the label alone.

Let $B_t$ be incremental monetary benefits and $C_t$ incremental investment costs in period $t$, valued on the same price basis, with discount rate $r$ and horizon $T$. Under the net-return convention, for positive present-value investment cost:

$$PV(B)=\sum_{t=0}^{T}\frac{B_t}{(1+r)^t},\qquad PV(C)=\sum_{t=0}^{T}\frac{C_t}{(1+r)^t},\qquad ROI_{\mathrm{net}}=\frac{PV(B)-PV(C)}{PV(C)}.$$

The corresponding gross benefit-cost ratio is $BCR=PV(B)/PV(C)=1+ROI_{\mathrm{net}}$, provided both use the same cost boundary. If an analysis instead defines the denominator as initial capital only or includes downstream costs within net benefits, it must show that alternative specification explicitly; ratios from different conventions are not directly comparable.

Worked example

Consider a prevention programme that costs £100,000 now and produces £70,000 of attributable monetary benefits at the end of each of the next two years, with no other incremental costs. At a 5% annual discount rate, the present value of benefits is approximately £130,159, so the net present value is approximately £30,159.

$$PV(B)=\frac{70{,}000}{1.05}+\frac{70{,}000}{1.05^2}\approx \pounds 130{,}159,\qquad ROI_{\mathrm{net}}=\frac{130{,}159-100{,}000}{100{,}000}\approx 0.302.$$

This is about a 30.2% discounted net return over the stated two-year horizon, while the gross benefit-cost ratio is about 1.302 to 1. It is not an annual investment yield, and the estimate changes if the comparator, attribution, prices, timing, or eligible benefit categories change.

Decision interpretation and limitations

A positive net ROI means monetised incremental benefits exceed the specified investment cost under the analysis assumptions. It does not show that the programme is the best use of a constrained budget: a smaller programme can have a higher ratio yet deliver less total net benefit than a larger feasible option.

Use net present value alongside the ratio when comparing mutually exclusive options or different project sizes. If key health outcomes cannot be credibly monetised, present them separately and consider cost-effectiveness analysis rather than claiming that an ROI captures all value.

Health economic applications and distinctions

ROI is commonly used in public-health investment cases, workforce programmes, and service redesign to express monetised benefits relative to the resources invested. The accounting perspective matters particularly when improved health generates value outside the investing organisation and financial savings do not flow back to its budget.

Cost-effectiveness analysis reports cost per health outcome, such as cost per quality-adjusted life-year, without requiring that health benefit to be priced in money. Cost-benefit analysis monetises benefits and costs and can report net present value or a benefit-cost ratio; ROI is a specified ratio derived from such monetary flows, not a substitute for reporting the underlying outcomes and assumptions.

Evidence base

An investment case must explain attribution, valuation, and discounting so another analyst can reproduce the return. For public appraisal, the HM Treasury Green Book discusses discounted social benefits and costs and summary metrics; WHO's investment-case guidance addresses health-sector ROI applications. The CDC's public-health cost-benefit guidance provides the wider monetary evaluation context.